American Century Companies’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
GC
American Century Companies's FLNA Position: Q2 2026 in Review
American Century Companies sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 53,367 shares — an estimated $90.2K sold.
American Century Companies first reported a position in FLNA in Q3 2025 and held it in 3 quarters. The position peaked at $113K in Q3 2025. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- American Century Companies reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
- American Century Companies sold 53,367 Filana Therapeutics shares in Q2 2026, an estimated $90.2K.
- American Century Companies first reported a position in Filana Therapeutics in Q3 2025 and held it in 3 quarters.
- American Century Companies's Filana Therapeutics position peaked at $113K in Q3 2025.
- 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.